Lv1
30 积分 2026-03-27 加入
Advances in the treatment of bleeding disorders
5个月前
已完结
Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United States
5个月前
已完结
Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice
5个月前
已完结
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
5个月前
已完结
皖公网安备34019202002308
